Discussion on Valeant's worth and the company's struggles with Stelios Papadopoulos, Biogen chairman.
Dissecting the latest Fed action and forecasting what's to come with the Fast Money panel.
The biotech sector has been sliding, but a turnaround could be afoot. Chad Morganlander of Stifel Nicolaus and Craig Johnson of Piper Jaffray discuss with Brian Sullivan.
Treasury yields rose after Fed Chair Janet Yellen said that an interest rate hike is "probably" appropriate in the near-term if data improves.
Discussing the tech sector with Michael Cuggino, Permanent Portfolio Funds, and Nancy Tengler, Heartland Financial.
CNBC's Rick Santelli looks at the bond pit reaction to Janet Yellen's remarks at Harvard University.
"FMHR" traders Jim Lebenthal and Sarat Sethi give their value trade picks, and John Spallanzani, GFI Group, weighs in.
CNBC's Mike Santoli digs into the momentum in the IPO market.
CNBC's Mary Thompson looks at Thursday's six initial public offerings and whether this means the IPO market is back in business.
European stocks eked out gains on Friday amid a decline in oil prices.